PerkinElmer Invests in Carterra, the Leader in Label-Free High Throughput Antibody Screening and Characterization
PerkinElmer Invests in Carterra, the Leader in Label-Free High Throughput Antibody Screening and Characterization Share Article Carterra, Inc. announced that they have closed on a round of equity financing led by PerkinElmer, Inc. Carterra LSA Instrument We are thrilled to have PerkinElmer as an investor and look forward to working together to advance our shared visions to improve drug discovery and life science research. SALT LAKE CITY (PRWEB) December 14, 2020 Carterra, Inc., the world leader in label-free high throughput anti...
Source: prweb.com